Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Other • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Food & Beverage • Logistics (& Distribution) |
Stages | Expansion, MBO/LBO, Restructuring |
Investing | Australia • New Zealand |
Investment Range | €1,820,000 - €1,820,000 |
Crescent Capital Partners is an established private equity firm specializing in mid-market investments across Australia and New Zealand, particularly emphasizing sectors like healthcare, industrial, financial services, and technology. Founded in 2000 and headquartered in Sydney, their investment approach is tailored to nurture growth and restructuring, target expansion and MBO/LBO opportunities, and help companies enhance performance or consolidate their market sectors. With a significant expertise in Equity, Crescent prides itself on a high engagement model, which has consistently resulted in profit growth that outperforms industry benchmarks. Over the past 25 years, Crescent has cemented their position as a leading private equity firm in healthcare, dedicating 45% of their funds to this sector, generating top decile outcomes globally. Crescent's investment strategies include private equity funds focusing on consumer health, private credit funds, and listed equities. The firm collaborates with major banks to offer two: the Crescent Corporate Loan Fund and the Crescent Structured Credit Fund. These provide investors access to diversified portfolios of Australian corporate loans and asset-backed and infrastructure junior debt, respectively. Crescent Capital adopts a unique investment philosophy, looking for companies with strong margins and market positions in sectors with positive momentum. They aim to create value through clear investment theses, and their team's deep in-house experience supports emerging and growth-stage companies. The firm also exhibits a strong commitment to responsible investing by integrating ESG considerations throughout the investment lifecycle. With seven funds and multiple continuation vehicles, Crescent manages over $3.5 billion in funds under management and boasts exceptional investment performance with a gross return IRR of 25% across all investments. Their team's average partner tenure is over 20 years, exemplifying the firm's stability and experience. Crescent Capital's dedication to forming enduring relationships with businesses and investors is evident in their successful track record and responsible investment practices.